Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

61.62
Delayed Data
As of Dec 06
 +0.76 / +1.25%
Today’s Change
50.71
Today|||52-Week Range
68.12
+4.02%
Year-to-Date
AbbVie, Johns Hopkins Unite for Cancer Research
Dec 06 / GuruFocus News - Paid Partner Content
AbbVie Crohn's Disease Drug Gets Orphan Drug Status in U.S.
Dec 01 / Zacks.com - Paid Partner Content
AbbVie (ABBV) Presents Impressive Imbruvica Data at ASH
Dec 06 / Zacks.com - Paid Partner Content
Momenta Pharmaceuticals Announces Positive Results for Humira Biosimilar
Nov 30 / GuruFocus News - Paid Partner Content
Leukemia Treatment Achieves Promising Results
Dec 05 / GuruFocus News - Paid Partner Content
Momenta/Shire's Humira Biosimilar Meets Study Objective
Nov 30 / Zacks.com - Paid Partner Content
Amgen/Allergan File for EU Approval of Avastin Biosimilar
Dec 05 / Zacks.com - Paid Partner Content
Why the $324 Billion Bioeconomy Deserves a Place in Your Portfolio
Nov 30 / MotleyFool.com - Paid Partner Content
FDA Orphan Drug Designation for AbbVie's Risankizumab
Dec 01 / GuruFocus News - Paid Partner Content
Big Pharma healthcare R&D steps out into the open
Nov 29 / FT.com - Paid Partner Content

Today’s Trading

Previous close60.86
Today’s open60.76
Day’s range60.33 - 61.72
Volume7,610,418
Average volume (3 months)7,276,451
Market cap$98.9B
Dividend yield4.15%
Data as of 12/06/2016

Growth & Valuation

Earnings growth (last year)+184.55%
Earnings growth (this year)+12.35%
Earnings growth (next 5 years)+15.41%
Revenue growth (last year)+14.52%
P/E ratio16.7
Price/Sales4.24
Price/Book24.84

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.48+0.86%
SNYSanofi-0.25-0.61%
GSKGlaxoSmithKline+0.02+0.05%
CELGCelgene+0.83+0.71%
Data as of 8:18am ET, 12/07/2016

Financials

Next reporting dateFebruary 3, 2017
EPS forecast (this quarter)$1.19
Annual revenue (last year)$22.9B
Annual profit (last year)$5.1B
Net profit margin22.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts


Search for Jobs